ERIN SHOOSHAN: Open Payments
NPI 1396749909 · QUEENSBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 12 payments from 6 companies in 2025. Trend: 2023 $211 · 2024 $400 · 2025 $475
Food & beverage: $386Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $207 |
| BridgeBio Pharma, Inc. | 2 | $115 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $83 |
| Amgen Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: UPTRAVI, Attruby, OPSUMIT, LifeVest, REPATHA, VERQUVO, LOKELMA.
Industry payments across NY — which companies pay providers there.
